Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer

Results from a randomized clinical trial show patients with HPV-positive oropharyngeal cancer treated with radiation and cetuximab had inferior survival compared to the current standard treatment with radiation and cisplatin. The trial's goal was to find a less toxic treatment approach without compromising survival.

https://ift.tt/2vDkkhp